Search Results 71-80 of 18626 for celiacs disease
A Study of the Safety, Pharmacodynamics, Effectiveness, and PK of TIMP-GLIA in Subjects with Celiac Disease · Overview · Participation eligibility · Participating ...
A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in People With Celiac Disease · Overview · Participation eligibility.
Mayo Clinic gastroenterologist Dr. Joseph Murray says only about 1 percent of Americans have celiac disease and should not eat gluten, the.
Potentially Resectable Pancreatic Cancer - No involvement of the celiac artery, common hepatic artery, and superior mesenteric artery (SMA) and, if present, ...
... Celiac disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.
A Study to Evaluate the Effectiveness and Safety of PRV-015 in Adult Patients wth Non-responsive Celiac Disease as an Adjunct to a Gluten-free Diet.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
If you have celiac disease and eat foods containing gluten, an immune reaction happens that causes damage to the surface of your small intestine. This leads to ...
Celiac Disease Registry. Rochester, Minn. The purpose of this study is to develop a resource (bank) of biospecimens (blood, tissue, stool) and data collected ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.